CN105918586A - Making technology of Maca tablets - Google Patents
Making technology of Maca tablets Download PDFInfo
- Publication number
- CN105918586A CN105918586A CN201610244355.4A CN201610244355A CN105918586A CN 105918586 A CN105918586 A CN 105918586A CN 201610244355 A CN201610244355 A CN 201610244355A CN 105918586 A CN105918586 A CN 105918586A
- Authority
- CN
- China
- Prior art keywords
- maca
- parts
- xylitol
- maltodextrin
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000000421 Lepidium meyenii Nutrition 0.000 title claims abstract description 39
- 240000000759 Lepidium meyenii Species 0.000 title claims abstract description 39
- 235000012902 lepidium meyenii Nutrition 0.000 title claims abstract description 39
- 238000005516 engineering process Methods 0.000 title claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 26
- 239000008187 granular material Substances 0.000 claims abstract description 22
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 15
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 15
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000811 xylitol Substances 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 15
- 229960002675 xylitol Drugs 0.000 claims abstract description 15
- 235000010447 xylitol Nutrition 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 9
- 230000005855 radiation Effects 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000005303 weighing Methods 0.000 claims abstract description 4
- 238000012545 processing Methods 0.000 claims description 14
- 241000219780 Pueraria Species 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000000080 wetting agent Substances 0.000 claims description 7
- 239000011230 binding agent Substances 0.000 claims description 5
- 238000007689 inspection Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 2
- 230000035558 fertility Effects 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 230000036299 sexual function Effects 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract 2
- 238000009924 canning Methods 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000003867 tiredness Effects 0.000 abstract 1
- 208000016255 tiredness Diseases 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 5
- 230000009182 swimming Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000004383 glucosinolate group Chemical group 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- QAADZYUXQLUXFX-UHFFFAOYSA-N N-phenylmethylthioformamide Natural products S=CNCC1=CC=CC=C1 QAADZYUXQLUXFX-UHFFFAOYSA-N 0.000 description 1
- 241000245301 Nymphoides Species 0.000 description 1
- 235000000476 Nymphoides peltata Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000719 anti-leukaemic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/06—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing beet sugar or cane sugar if specifically mentioned or containing other carbohydrates, e.g. starches, gums, alcohol sugar, polysaccharides, dextrin or containing high or low amount of carbohydrate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/14—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing fruits, nuts, e.g. almonds, seeds, plants, plant extracts, essential oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a making technology of Maca tablets. The making technology comprises the following steps of separately taking the following components in parts by weight: 94-96 parts of Maca powder, 2-3 parts of xylitol and 2-3 parts of maltodextrin, performing weighing and compounding, then performing mixing, and performing radiation treatment; performing crushing and screening; performing granulation and drying, namely enabling the crushed and screened mixture to be gathered into a coarse powder ball, and performing drying treatment, wherein the drying temperature is 40-55 DEG C, the drying time is 5-9h, and the inspected water content is 3-5%; performing granule separation and overall mixing: performing granule separation, then performing overall mixing, and performing extraction and selective examination on content and moisture content; and performing tabletting and canning. The Maca tablets disclosed by the invention have the efficacies of rapidly complementing physical strength and allaying tiredness, and after the Maca tablets are eaten for a long term, the sexual function and the fertility ability can be enhanced.
Description
Technical field
The invention belongs to food processing field, particularly to the processing technology of a kind of Maca sheet.
Background technology
Lepidinm meyenii Walp (Maca), originates in the mountain area, Andean, South America of height above sea level 3500～4500 meters, now
It is mainly distributed on the Puno ecotope in the middle part of Peru and Peru the southeastern city of Puno, for Cruciferae
(Cruciferae) only floating heart.
The chemical constitution study of Lepidinm meyenii Walp starts to increase the sixties, containing Lepidinm meyenii Walp phthalein amine (mac；Amides) and
Lepidinm meyenii Walp alkene mac；And the Secondary metabolites such as glucosinolate, sterol aenes),.Italy's science
The chemical composition composition that family Dini A the most systematically drew in the dry root of Maca in 1994: protein
Content is more than 10% (protein content of the Maca kind of Hu Ning lakeside is more than 14%), the carbon of 59%
Hydrate；The fiber of 8.5%, include abundant zinc, calcium, ferrum, titanium, rubidium, potassium, sodium, copper, manganese,
The mineral such as magnesium, strontium, phosphorus, iodine, and containing vitamin C, B1, B2, B6, A, E, B12,
B5, fat content is the highest but mostly wherein is unsaturated fatty acid, and the content of linoleic acid plus linolenic acid reaches 53%
Above, natural activity composition includes alkaloid, glucosinolate and catabolite benzyl isothiocyanate, steroid
Alcohol, polyphenols etc..1999, American scientist was found that in Maca the plant new containing two classes
Active ingredient, macamides (macamides) and Maca dilute (macaenes), and determine both materials pair
Balanced human's hormone secretion has remarkable effect, the natural hormone electromotor so Maca is otherwise known as.?
In the specific aim research of Maca product, it is found that again several special Maca alkaloid, deep along with study
Enter, Maca also has the most active novel substance and is isolated and identified.Ministry of Public Health was in 2011
Approval Lepidinm meyenii Walp is country's new resource food.
High nutritive value, rational trophic structure and multiple there is bioactive secondary metabolite make
Lepidinm meyenii Walp possesses plurality of health care functions, can be used for traditionally strengthening energy, improves fertility, improve sexual function,
Treatment climacteric syndrome, rheumatism, depression, anemia, the merit of the most anticancer and anti-leukemia
Effect, modern medicine study shows, Lepidinm meyenii Walp has the multiple unique effects such as resisting fatigue, endocrine regulation.
At present, the deep processed product of Lepidinm meyenii Walp is actually rare on the market, does not also have more ripe processing technology.
Summary of the invention
It is an object of the invention to be, it is provided that the processing technology of a kind of Maca sheet.
Realization the technical scheme is that, the processing technology of a kind of Maca sheet, it comprises the steps:
Step one, taking maca powder, xylitol, maltodextrin according to weight portion is respectively: maca powder 94～96
Part, xylitol 2～3 parts, maltodextrin 2～3 parts carry out weighing proportioning, then mix, radiation treatment；
Step 2, pulverizes and sieves, and processes according to 80～120 mesh sieves after pulverizing；
Step 3, pelletizes and is dried so that above-mentioned pulverize and sieve after mixture be polymerized to coarse powder group, and be dried
Processing, wherein, baking temperature is 40～55 degree, and drying time is 5～9h, and inspection water content is 3%～5%；
Step 4, granulate always mixes, and always mixes again and extract selective examination content and moisture after granulate；
Step 5, tabletting is canned.
Further, in above-mentioned steps one, pueraria root powder is 95 parts, xylitol 2 parts, maltodextrin 3
Part.
Further, after above-mentioned steps two pulverizes and sieves, add wetting agent, binding agent and disintegrate
Agent.
Further, before always mixing after above-mentioned steps four granulate, wetting agent and disintegrating agent have been also added with it.
Compared with prior art, the sugared agate that the processing technology of a kind of Maca sheet of the application present invention is made
Card, is used in the penetrating odor that can effectively remove Maca itself in confection in right amount by maca powder, improves
Maca taste so that it is Maca fragrance more alcohol itself and, also enrich the taste of confection simultaneously, make agate
Block this resource to be fully obtained by, can be that human body supplements multiple nutrients and trace while chewable candies
Element, is conducive to playing the mutual synergistic effect of the composition in each raw material, its suitability dysfunction, easily
Fatigue, weak and sickly, subhealth state；Women’s climacteric and endocrine disturbance, sleep disorder crowd.Also have
It is improved energy, effect of fatigue alleviating.
Detailed description of the invention
The processing technology of a kind of Maca sheet of the present invention comprises the steps:
Step one, taking maca powder, xylitol, maltodextrin according to weight portion is respectively: maca powder 94～96
Part, xylitol 2～3 parts, maltodextrin 2～3 parts carry out weighing proportioning, then mix, radiation treatment；
Wherein, in the material of above-mentioned mixing, pueraria root powder is preferably 95 parts, and it is as major ingredient, xylitol 2
Part, maltodextrin 3 parts, should be both as adjuvant.The insect of remaining can be effectively killed by radiation treatment,
Worm's ovum and pathogenic bacteria etc..Or there is a following proportioning:
Pueraria root powder is 96 parts, xylitol 2 parts, maltodextrin 2 parts.
Pueraria root powder is 94 parts, xylitol 3 parts, maltodextrin 3 parts.
Pueraria root powder is 95 parts, xylitol 3 parts, maltodextrin 2 parts.
Step 2, pulverizes and sieves, and processes according to 80～120 mesh sieves after pulverizing；After pulverizing, before the drying,
Adding wetting agent/binding agent and disintegrating agent, they are as implant so that mixture makes soft material and wet
Grain.Above-mentioned wetting agent or binding agent can be selected for magnesium stearate, and proportion is a.The master of disintegrating agent
Act on and be to eliminate because the adhesion of binding agent makes disintegration of tablet.
Step 3, pelletizes and is dried so that above-mentioned pulverize and sieve after mixture be polymerized to coarse powder group, and carry out
Drying under reduced pressure process, wherein, baking temperature is 40～55 degree, and strict temperature control 55 degrees Celsius with
Under, the most easily make effective ingredient scatter and disappear or destroy, being dried under the reduced pressure atmosphere under slightly below normal pressure and also prevent
Only coarse powder group splits, and drying time is 5～9h, and inspection water content is 3%～5%；Wherein, granulation is preferably adopted
With wet granulation, the granule being made up of wet method is through moistened surface, and therefore its surface nature is preferable, profile
Attractive in appearance, wearability compared with strong, compressibility is good.
Step 4, granulate always mixes, and always mixes again and extract selective examination content and moisture after granulate, and granulate makes to be dried
During lump, the granule of adhesion scatter, to obtain granule of uniform size.Granule holds when granulate
Easily the fine powder in original granule is layered with granule, because fine powder can first pass through shaking screen with little granule,
Bulky grain can be stayed above, thus causes layering.If the most always mixed, fine powder, little granule and big
Grain is respectively on one side, and skewness, after granule subpackage, it is possible in the packaging bag having, fine powder is the most,
So when checking granularity, easily by numerical value bigger for granularity, may be defective.Wherein, granulate it
Before rear total mixed, it is also added with wetting agent and disintegrating agent, and volatile oil or volatile material, disintegrating agent
Main Function be to eliminate and formed the adhesion of tablet by pressurizeing and make disintegration of tablet.
Step 5, tabletting is canned, makes tablet molding.During tabletting, tie mainly by Van der Waals force between powder
Close.
Application Example one:
5mg/kg dosage every day (pueraria root powder is 95 parts, xylitol 2 parts, maltodextrin 3 parts)
Maca tablet carries out the nursing of 30 days to mice, after one month, according to " function of health food assessment process
With the method for inspection " in Loaned swimming test test in " alleviating physical fatigue detection method ", see table.
Find that more blank group of mice burden swimming time significantly extends, illustrate that taking Maca tablet can effectively alleviate
Tired.
Swimming with a load attached to the body test table
| Swimming time (min) | |
| Pueraria root powder is 95 parts, xylitol 2 parts, maltodextrin 3 parts | 21.9 |
| Blank example | 11.6 |
Application Example two:
The Double-blind randomized clinical trial carried out in 80 20-60 year healthy male subjects, by tested
Person is divided into two groups.
First group: every day twice, embodiment 1 Maca tablet of the most oral 3 0.3 gram/piece, continuously
After taking one month, test.
Second group, for blank group, refer to not use Maca tablet of the present invention and other similar health promoting products.
Result shows: after one month, group of people libido is significantly higher than second group.The present invention is described
Maca tablet can improve male's libido.
Although above in association with preferred embodiment, invention has been described, but those skilled in the art should
This understanding, method and system of the present invention is not limited to the embodiment described in detailed description of the invention,
In the case of without departing substantially from the spirit and scope of the invention being defined by the appended claims, can be to the present invention
Various modification can be adapted, increase and replace.
Claims (4)
1. the processing technology of a Maca sheet, it is characterised in that comprise the steps:
Step one, taking maca powder, xylitol, maltodextrin according to weight portion is respectively: maca powder 94～96
Part, xylitol 2～3 parts, maltodextrin 2～3 parts carry out weighing proportioning, then mix, radiation treatment；
Step 2, pulverizes and sieves, and processes according to 80～120 mesh sieves after pulverizing；
Step 3, pelletizes and is dried so that above-mentioned pulverize and sieve after mixture be polymerized to coarse powder group, and be dried
Processing, wherein, baking temperature is 40～55 degree, and drying time is 5～9h, and inspection water content is 3%～5%；
Step 4, granulate always mixes, and always mixes again and extract selective examination content and moisture after granulate；
Step 5, tabletting is canned.
2. the processing technology of Maca sheet as claimed in claim 1, it is characterised in that in above-mentioned steps
In one, pueraria root powder is 95 parts, xylitol 2 parts, maltodextrin 3 parts.
3. the processing technology of Maca sheet as claimed in claim 1, it is characterised in that in above-mentioned steps
After two pulverize and sieve, add wetting agent, binding agent and disintegrating agent.
4. the processing technology of Maca sheet as claimed in claim 1, it is characterised in that in above-mentioned steps
Before always mixing after four granulate, wetting agent and disintegrating agent and volatile oil are also added with it.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610244355.4A CN105918586A (en) | 2016-04-19 | 2016-04-19 | Making technology of Maca tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610244355.4A CN105918586A (en) | 2016-04-19 | 2016-04-19 | Making technology of Maca tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105918586A true CN105918586A (en) | 2016-09-07 |
Family
ID=56838363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610244355.4A Pending CN105918586A (en) | 2016-04-19 | 2016-04-19 | Making technology of Maca tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105918586A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106579410A (en) * | 2016-12-12 | 2017-04-26 | 北京茗束商贸有限公司 | Maca, ginseng and Lycium ruthenicum Murr. tablet and preparation method thereof |
| CN106983141A (en) * | 2017-03-21 | 2017-07-28 | 北京活力达生物健康科技股份有限公司 | A kind of Maca tablet for improving energy and preparation method thereof |
-
2016
- 2016-04-19 CN CN201610244355.4A patent/CN105918586A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106579410A (en) * | 2016-12-12 | 2017-04-26 | 北京茗束商贸有限公司 | Maca, ginseng and Lycium ruthenicum Murr. tablet and preparation method thereof |
| CN106983141A (en) * | 2017-03-21 | 2017-07-28 | 北京活力达生物健康科技股份有限公司 | A kind of Maca tablet for improving energy and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102415534A (en) | Maca apple tablet and preparation method thereof | |
| CN105685869A (en) | Dragon fruit stem chewable tablets and preparation method thereof | |
| CN104306617A (en) | Maca and Acai-containing composition as well as preparation method and application thereof | |
| CN104187592A (en) | Truffle slices and preparation method thereof | |
| CN102085356B (en) | Composition for increasing bone mineral density and preparation method thereof | |
| CN106722455A (en) | calcium fruit chewable tablets and preparation method thereof | |
| CN101129193B (en) | Compound high calcium tablet of yak medulla and method of preparing the same | |
| EP1488797B1 (en) | Oral preprations having itching-relieving or antipruritic activity | |
| CN108888601A (en) | A kind of vitamin E selenium microcapsules tablet, preparation method and its usage | |
| CN106036898A (en) | Composition having anti-fatigue effects and preparation method and use thereof | |
| KR102014675B1 (en) | Method of producing a granular health funciotnal food | |
| CN107691746A (en) | High selenium broccoli pressed candy and preparation method thereof | |
| CN107616289A (en) | A kind of mushroom pressed candy and preparation method thereof | |
| CN105918586A (en) | Making technology of Maca tablets | |
| CN105768093A (en) | Maca tablets | |
| CN107397032A (en) | A kind of fruits and vegetables pressed candy and preparation method thereof | |
| CN107811095A (en) | A kind of preparation method of the compound pressed candy of pomegranate jujube | |
| CN103609994B (en) | A kind of oral tablet containing Noni fruit composition and preparation method thereof | |
| CN104544057A (en) | Inulin lozenge and preparation method thereof | |
| CN105876049A (en) | Making technology of lepidium meyenii candies | |
| CN105054041A (en) | Fatigue preventing maca tablet | |
| CN104247771A (en) | Spirulina milk tablet | |
| KR101169931B1 (en) | Health supplement comprising wild―peach powder as a staple ingredient and the manufacturing method thereof | |
| CN104431857A (en) | Olive lozenge and production process thereof | |
| CN101485464B (en) | Intestine-benefiting Chinese medicine additive agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160907 |
|
| WD01 | Invention patent application deemed withdrawn after publication |